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ABSTRACT Due to their biocompatibility and small size, iron
oxide magnetic nanoparticles (MNP) can be guided to virtually
every biological environment. MNP are susceptible to external
magnetic fields and can thus be used for transport of drugs and
genes, for heat generation in magnetic hyperthermia or for contrast
enhancement in magnetic resonance imaging of biological tissue. At
the same time, their magnetic properties allow one to develop
sensitive and specific measurement methods to non-invasively
detectMNP ,toquantifyMNPdistributionintissueandtodetermine
their binding state. In this article, we review the application of
magnetorelaxometry (MRX) for MNP detection. The underlying
physical properties of MNP responsible for the generation of the
MRXsignalwithitscharacteristicparametersofrelaxationamplitude
and relaxation time are described. Existing single and multi-channel
MRX devices are reviewed. Finally, we thoroughly describe some
applications of MRX to cellular MNP quantification, MNP organ
distribution and MNP-based binding assays. Providing specific MNP
signals, a detection limit down to a few nanogram MNP , in-vivo
capability in conscious animals and measurement times of a few
seconds, MRX is a valuable tool to improve the application of
MNP for diagnostic and therapeutic purposes.
INTRODUCTION
Physics of Magnetic Nanoparticles
Iron oxide nanoparticles represent a major class of particles
used for novel magnetic applications in biomedicine, such
as magnetic drug targeting, magnetic thermoablation,
biosensors or molecular imaging. An overview over these
applications is given in a number of review articles (1–8).
Magnetic nanoparticles that are used for medical applica-
tions consist of a magnetite or maghemite core surrounded
by a stabilizing and biocompatible coating. Due to the
small core diameter of typically 4-30 nm, 10
3–10
4 atomic
magnetic moments within one particle are coupled together
resulting in a single domain of uniform magnetization with
a total magnetic moment m given by
m ¼ MpVp ð1Þ
where Mp denotes the magnetization of the core material
and Vp the core volume of the particle. Note that Mp is
usually smaller than the saturation magnetization MS of the
bulk material.
Without an external field, the magnetic moments of an
ensemble of magnetic nanoparticles in thermal equilibrium
will be randomly oriented and no net magnetic moment
will be seen in a distance from the assembly. In the presence
of a magnetic field H, the magnetic moments of the
nanoparticles will tend to align along the field direction,
a n dan e tm a g n e t i cm o m e n tw i l lb eg e n e r a t e d .T h i s
phenomenon is commonly referred to by the notion
superparamagnetism.
For isotropic and non-interacting particles in thermal
equilibrium at a temperature T the fraction of the magnetic
moments that are aligned give rise to the net magnetization
M(H,T ) that is described by the Langevin function relating
the magnetic energy μ0H to the thermal energy kBT
MðH;TÞ¼Mp coth
mm0H
kBT
  
 
kBT
mm0H
  
ð2Þ
The equilibrium magnetization arising from a change of
the external magnetic field H is not reached instantaneously
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nanoparticlebiodistributionbut after a characteristic time τD by rotational diffusion of
the magnetic moments within the particles, where (9).
tD ¼
3hmVp
kBT
ð3Þ
The parameter hm ¼ MS=ð6agÞ denotes some kind of
“magnetic” viscosity which hampers the rotational move-
ment of the magnetic moments. The damping α and the
gyromagnetic ratio γ are internal parameters characteristic
of the particular nanoparticles’ crystal structure.
The actual magnetization behaviour of most magnetic
nanoparticles is not isotropic, because of the presence of an
effective magnetic anisotropy K, generally arising from a
combination of magnetocrystalline and shape anisotropy.
Due to this anisotropy, the magnetic moment has preferred
orientations within the particle, along so-called easy axes
representing local energy minima. For the simplest case of
uniaxial anisotropy the energy barrier separating two minima
is proportional to the volume of the particle, EA = KV p and
the probability at a temperature T to surmount this energy
barrier is given by the Néel relaxation time τΝ (10)
tN ¼ t0 exp
KVp
kBT
  
ð4Þ
where t0 ¼ 3hm=K is a damping or extinction time with
values between 10
−8 sa n d1 0
−12 s( 11)a n dk B is the
Boltzmann constant.
An additional relaxation mechanism appears if the
magnetic nanoparticles are suspended in a carrier fluid of
viscosity η, where the particles may rotate together with
their magnetic moments. This is described by the Brownian
relaxation time τB
tB ¼
3hVh
kBT
ð5Þ
with Vh denoting the hydrodynamic volume. Note that the
rotating structure is not necessarily a single particle; it
might be composed of several nanoparticles or of a
magnetic nanoparticle bound to other colloidal objects. In
any case, Vh in Eq. 5 refers to the overall hydrodynamic
volume of the rotating colloidal structure.
If both relaxation mechanisms are present at the same
time, the overall relaxation behaviour is described by an
effective relaxation time τeff (12)
teff ¼
tNtB
tN þ tB
ð6Þ
with the shortest relaxation time prevailing. Figure 1 shows
a logarithmic 2D plot of the effective relaxation time for
different Néel and Brownian relaxation times according to
Eq. 6 together with the corresponding core and hydrody-
namic diameter assuming spherical magnetite MNP with
an effective anisotropy K~10
4 J/m
3. Additionally, the
increase of relaxation time by increasing the shell thick-
nesses from 5 nm (white line) to 10 nm (red line) is
visualized. This effect is much less pronounced when the
total diameter is increased from 150 nm (orange line) to
160 nm (black line).
Real nanoparticle systems usually exhibit a distribution
of particle sizes and thereby also a distribution of relaxation
times. Often, the log-normal distribution PP(Vp) is taken to
describe the particle core volume distribution
PPðVP;mP;sPÞ¼
1
ﬃﬃﬃﬃﬃ
2p
p
sP VP
exp  
ln2ðVP=mpÞ
2s2
P
 !
ð7Þ
where μp is the median particle core volume and σp the
standard deviation of the core volume distribution. Since
according to Eq. 4 the Néel relaxation time depends on the
core volume, the log-normal distribution of nanoparticle
sizes also entails a log-normal distribution of relaxation
times.
The distribution function Ph(Vh) of the hydrodynamic
diameters is more variable and typically more complicated.
An obvious lower bound is that for a given particle Vh > Vp.
Typical cases that can easily be modeled:
a) Single (spherical) nanoparticles with a fixed shell
thickness ds: Vh = π(dP +2 ds)
3/6. In this case, Vh is
still in the order of Vp.
b) Single nanoparticles where the shell thickness has another
functionaldependenceontheparticlediameter:Vh =f ( VP).
Also in this case, Vh is typically in the order of Vp.
c) Aggregates of colloidal compartments with a lognormal
distribution of aggregate volume characterized by its
median μh and distribution width σh.
Ph Vh;mh;sh ðÞ ¼
1
ﬃﬃﬃﬃﬃ
2p
p
shVh
exp  
ln2 Vh=mh ðÞ
2sh
  
ð8Þ
In this case, Vh»Vp. The colloidal compartments might
be magnetic, they might also consist of non-magnetic
material. A special case of aggregates are so-called
multicore particles, where a number of smaller mag-
netic cores are assembled within one organic shell. Due
to the close distance between the different cores, the
magnetic interaction between them can no longer be
neglected for these multicore particles.
d) Immobilization of the nanoparticles to large or fixed
objects: Vh = ∞ for all MNPs in the sample.
A superposition of these cases occurs in real world
nanoparticle suspensions.
Due to the widely variable hydrodynamic diameter in
colloidal dispersions, the effective relaxation time is only
1190 Wiekhorst, Steinhoff, Eberbeck and Trahmsloosely dependent on the particle core volume as shown in
Fig. 2.
For a magnetic nanoparticle suspension, the overall
distribution function of effective relaxation times is
characterized by pairs of core volume and hydrody-
namic volume:
P ¼ PV p;Vh
  
ð9Þ
Obviously, for a given particle formulation, the distri-
bution of core diameters is independent of the binding
state, whereas the hydrodynamic diameters and thus the
effective relaxation times will be altered by a binding
reaction or a cluster formation.
Magnetorelaxometry: Measurement Procedures
and Experimental Implementation
The phenomenon of delayed magnetic response of ferri- or
ferromagnetic materials to sudden changes of an external
applied magnetic field has long been known and is
commonly denoted as magnetic relaxation, magnetic viscosity or
magnetic after effect (13). More recently, it was recognized that
the measurement of this effect, i.e. in particular the
measurement of the time dependent response of super-
paramagnetic nanoparticles to a sudden switch-off of the
magnetic field, can be utilized to obtain specific informa-
tion about the nanoparticles and their environment (14).
Specific techniques and procedures of the measurement of
these relaxation effects in magnetic nanoparticles are
subsumed under the concept magnetorelaxometry.
As depicted in Fig. 3, a magnetorelaxometric measure-
ment generally consists of two phases: A magnetizing phase
when a magnetizing field of defined strength and duration
partly aligns the MNP moments into the field direction, and
a measurement phase, during which, shortly after the
switching-off of the magnetizing field, the decaying mag-
netic field originating from the decay of the samples net
magnetic moment is detected by a sensitive magnetic field
sensors like SQUID, fluxgate (15) or optical magnetometer
(16). The latter two sensor types enable even the observa-
tion of the magnetic nanoparticles during the magnetizing
phase.
Fig. 1 Logarithmic 2D plot of the
effective relaxation time combining
Néel (abscissa, Eq. 4) and Brownian
relaxation (ordinate, Eq. 5)a c c o r d -
ing to Eq. 6. Furthermore, the
corresponding core and hydrody-
namic diameter are displayed for
magnetite MNP with an effective
anisotropy K~10
4 J/m
3.T h e
straight lines have been added to
show the influence of a fixed shell
thickness of 5 nm (white line),
10 nm (red line) or a fixed hydro-
dynamic diameter of 150 nm (or-
ange line) and 160 nm (black line)
on the relaxation time with increas-
ing core diameter.
Fig. 2 Effective relaxation time calculated by Eqs. (4–6) for different magnetic
core diameters dp as a function of the hydrodynamic diameter dh for
Keff=10
4 J/m
3, T=290 K and η=10
−3 Pa·s. The shaded area is accessible
by our MRX setup (10
−4 st o1 0
2 s), as determined by SQUID electronics
dead time, sampling frequency and relaxation measurement interval. The
green line indicates particles without a nonmagnetic shell layer where dh=dp.
Immobilized particles are detectable only if they have a core diameter dp of
about 16 nm to 22 nm. If both Brownian and Néel relaxation are present,
particles with dp larger than 16 nm and at the same time dh in the range from
50 nm to 5 μm are detectable by MRX. For particles with dp≥23 nm, only
Brownian relaxation can be observed in the given time interval.
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The net magnetization of a magnetic nanoparticle sample
achieved at the end of the MRX magnetizing phase
crucially depends on strength Hmag and duration tmag of
the externally applied magnetic field. Since a magnetic field
reduces the barrier to reach the energy minimum in the
Néel relaxation process and acts as a torque in the
Brownian relaxation mechanism, we have to take into
account the field influence on the magnetization time of the
individual particles. For the Néel relaxation we have (17)
tmag;NðHÞ¼tN 1  
0:82m0HMS
K
  
where τN is the Neel relaxation time as defined in Eq. 4.
More sophisticated approaches for the field dependency of
the Néel relaxation are discussed in (18) Accordingly, for
Brownian relaxation the field dependency is found by
simulations (19)
tmag;BðHÞ¼tB 1 þ 0:21
mm0H
kBT
   2  !  1=2
If both mechanisms are present, the resulting effective
relaxation time τmag(H) is given by Eq. 6 again. Thus, the
initial magnetization amplitude M0 after a magnetization
time tmag is then
M0 tmag
  
¼
Z
VP
Z
Vh
MV p;Hmag;T
  
1  exp  tmag=tmag Hmag;Vp;Vh;T
        
PV P;Vh ðÞ dVhdVP
Here, M(Vp,Hmag,T ) is the equilibrium value calculated
according to Eq. 2. The total magnetic moment of the
sample is the superposition of the magnetic moments of all
single particles that were aligned by this procedure. Thus,
the measurement of their subsequent relaxation by magne-
torelaxometry represents an integral view on the ensemble
of the magnetic nanoparticles in the sample.
The Relaxation of the Magnetic Nanoparticles
For a magnetic nanoparticle sample the relaxation process
is described by
MðtÞ¼
Z
Vp
Z
Vh
M0 Vp;Vh
  
exp  t=teff Vp;Vh
     
PV p;Vh
  
dVh dVP
ð11Þ
From the measured MRX relaxation curve two
parameters can be extracted that describe its main
features, the relaxation amplitude ΔB and a relaxation
decay time t1/e. The MRX relaxation amplitude is the
magnetic field change between two selected time points
within the recorded relaxation time interval. The MRX
decay time t1/e denotes the time after which the magnetic
field value taken at a selected start point dropped by the
factor e≈2.718.
The appropriate number and type of magnetic field
sensors for measuring the relaxation of the sample‘s
effective magnetic moment is determined by the particular
application. For several applications fluxgate and optical
magnetometer having detection sensitivities down to
10
−12 T·Hz
−1/2 with a maximum bandwidth of about
10 kHz offer an acceptable way to apply magnetorelaxom-
etry (15,16). At the cost of higher technical effort, the best
sensitivity so far is reached by low Tc superconducting
quantum interference devices (SQUIDs). These sensors
enable the detection of magnetic fields as small as a few
10
−15 T·Hz
−1/2, their bandwidth can reach several MHz.
For measurement of samples at room temperature, the
minimum distance between sample and SQUID is limited
by the requirements of thermal insulation.
A sample of volume V containing a magnetization
distribution M(r,t) originating from magnetic nanoparticles
generates a magnetic flux density B(r,t) (hereafter simply
termed magnetic field) outside the sample
Bðr;tÞ¼
m0
4p
Z
V
3Mðr0;tÞ ð r   r0Þðr   r0Þ
r   r0 jj
5  
Mðr0;tÞ
r   r0 jj
3
 !
dV 0
ð12Þ
withtheintegrationcarriedoutoverthesamplevolumeV and
with μ0 (= 4π×10
−7 V·s/(A·m)) as the permeability of free
space. Due to the relaxation of the MNP after turning off the
Fig. 3 Magnetorelaxometry principle. The top line (from left to right)
portrays a nanoparticle ensemble‘s behavior: initially in a disordered state
without magnetization, partly rotated towards the field direction during
magnetizing, and turning back into a randomly oriented distribution of
magnetic moments leading to the detected magnetization relaxation.
Typically a field of about 1.5 mT is applied for 1 s. After removal of the
field and a short interval the SQUID amplifier needs to recover, the
relaxation signals are acquired for 0.5 s.
ð10Þ
1192 Wiekhorst, Steinhoff, Eberbeck and Trahmsmagnetizing field, the magnetization M and hence the
magnetic field B become time dependent. In cases where a
magnetic nanoparticle accumulation can be assumed to be
within a point-like region it can be described by a single
magnetic moment m(r’,t)a tr’.E q .12 simplifies then to the
well-known formula describing the field of a magnetic
dipole
Bðr;tÞ¼
m0
4p
mðr0;tÞ ð r   r0Þðr   r0Þ
jr   r0j
5  
mðr0;tÞ
jr   r0j
3
 !
ð13Þ
Equation 12 reflects the integral character of MRX:
after magnetizing the sample volume, all magnetic nano-
particles in this volume contribute to the measured
magnetic field signal at position r. As a consequence,
MRX reflects all magnetic nanoparticles in the sample
that exhibit a relaxation within the observation time
window.
The observation time window is limited by the dead
time of the SQUID sensor after the magnetizing field is
switched off and the ending of the recording interval of
the MRX signal. Particles having an effective relaxation
time according to Eq. 6 that is much shorter than the
dead time have decayed before they can be detected, thus
they do not contribute to the MRX signal just as the time
independent remanent magnetization. Further limiting
factors of the magnetorelaxometric measurement tech-
nique are the upper limit of the signal bandwidth fcutoff of
the magnetic sensors and the sampling frequency fs of the
data acquisition system, only relaxation times with τeff >
fs
−1 and τeff > fcutoff
−1 can be resolved.
The detection parameters limit the range of particle sizes
participating in the magnetorelaxometric measurement.
The limits can be estimated by Eq. 3 as shown in Fig. 2.
Assuming immobilized (Néel relaxation, solely) spherical
iron oxide particles with a typical effective anisotropy of
10
4 J/m
3, only particles having a core diameter of about
16 nm to 22 nm are detectable in the time window of MRX
(10
−4 st o1 0
2 s). If both Brownian and Néel relaxation are
present, MNPs having core diameters larger than 16 nm
and at the same time hydrodynamic diameters in the range
from 50 nm to 5 μm are detectable by MRX. For particles
with core diameters dp≥23 nm, only Brownian relaxation
can be observed in the given time interval.
Magnetorelaxometry Measurement Devices
In order to meet the technical requirements for the two
phases of a magnetorelaxometric measurement, an MRX
device is composed of a magnetizing unit and one or more
magnetic sensors that detect the relaxation. At present three
different MRX systems all based on low Tc superconduct-
ing quantum interference device (SQUID) sensors are in
use in our lab at PTB, as shown in Fig. 4. Low Tc SQUIDS
have to be operated at low temperatures that usually are
accomplished by housing the SQUIDs inside a Dewar
cryostat filled with liquid Helium. Two of our SQUID
based MRX devices are operated in a magnetically shielded
room that suppresses environmental magnetic noise from
outside, a third device has an integrated superconducting
shield of its own. Due to the high performance of the PTB
SQUID sensors and readout electronics, typically a
bandwidth from dc to several megahertz and a dynamic
range of over ±200 nT over a noise floor of 1.5 fT Hz
−1/2
can be achieved.
The single channel MRX system (1ch, Fig. 4a) used for
high resolution MRX combines two SQUID sensors to
form a spatial gradiometer arrangement for the suppression
of magnetic far field distortions. At a distance of 12 mm
below the nearest SQUID sensor located inside the tail of a
liquid helium Dewar the samples of 150 μlv o l u m e
(polyethylene microtiter vials) are placed inside the 10 mm
bore of a twin coil (i.e. two parallel coils with opposite
polarity to reduce their stray field at the SQUID location).
Alternatively, larger samples up to 8 ml volume can be
measured replacing the magnetizing coil by a larger twin
coil of 27.5 mm bore diameter. Both twin coil systems can
be energized by a magnetizing unit supplying magnetic
fields up to 2 kA/m (2.5 mT).
In the first step, the sample is magnetized for 1 s.
Following a 200 μs dead time interval after switching off
the magnetic field that is required to recover the SQUID
sensor electronics, the relaxation is recorded for typically
0.5 s, digitized at a 100 kHz sampling rate and 16 bit word
length. The bandwidth of the MRX device is limited by the
data acquisition unit. The short duration of one measure-
ment makes repetitive measurements feasible, which may
improve the signal-to-noise (SNR) ratio by signal averaging.
For this setting, relaxation amplitudes ΔB down to 1 pT can
be safely identified in an MRX measurement.
For MRX measurements of large sized samples up to
human body dimensions, the PTB 304 SQUID vector
magnetometer (Fig. 4c) is used—a home-made biomagnetic
measurement system where the 304 SQUIDS are arranged
in a large Dewar vessel in various orientations measuring
the three magnetic field components that make up the
magnetic field vector. For MRX applications this system is
combined with a magnetizing unit composed of a gradient
amplifier (Bruker) and a Helmholtz coil of 84 cm diameter
(Fig. 4d). A DC current of 80 A is fed into the coil to
provide a magnetizing field of 0.8 kA/m (1 mT). The large
stray field of the Helmholtz coil requires the operation of
the magnetizing coil outside the magnetically shielded room
and the subsequent transport of the magnetized sample into
the shielded room below the magnetometer. Since this
transport is currently done manually, a dead time of 5 s to
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magnetizing field has to be taken into account. To
compensate for this inevitably large dead time, the
magnetizing field is applied for 60 s. According to Eq. 10
an extension of the magnetization time to 60 s gives also the
large particles enough time to get aligned with the field so
that the magnetization has reached its maximum value (for
the given value of the magnetizing field). The data
acquisition at a sampling rate of 250 Hz starts 10 s prior
to switching off the magnetizing field by which the sample
transport and start of the relaxation process are recorded.
Thus the relaxation can be evaluated at the earliest
moment when the sample has come to rest. The relaxation
signals from the sample below the sensor are recorded for
at least 75 s. During transport and measurements the door
of the shielded room is kept open. This avoids further time
loss and perturbations by the operation of the heavy sliding
door, but admits the intrusion of low frequency magnetic
noise signals of ±5 pT amplitude during the measurement
phase, which limits the smallest detectable relaxation
amplitude ΔB to about 10 pT for this setting.
In the third MRX device (Fig. 4b), 18 Helium cooled
SQUIDs are arranged in a circle round a cylindrical
horizontal warm bore, with 11 cm diameter being large
enough to detect the relaxation signals from medium scale
accomplished by a cylindrical superconducting Niobium
shield which is integrated into this system. This magnetic
shield is assembled within the liquid Helium tank of the
Dewar vessel, but tightly aligned to the warm bore to keep
environmental magnetic distortions from the SQUIDs.
Sample magnetization can be performed either outside the
warm bore, where a large variety of magnetic field sources
can be used, or inside the warm bore at the sensor location
by a Helmholtz coil with fields up to 4 mT. With this setup,
the typical magnetizing duration amounts to 1 s followed by
a4 0 0μs dead time interval, thus the relaxation data are
acquired for 1 s at 100 kHz sampling rate and a 16 bit word
length. For this device, a relaxation amplitude ΔB down to
approximately 1 pT becomes detectable in an MRX
measurement.
APPLICATIONS
Exploiting the Relaxation Amplitude: Quantification
and Localization of Magnetic Nanoparticles
Administered to Organisms
The most relevant parameter for quantification and
localization of MNP is the MRX relaxation amplitude
ΔB. In addition, the relaxation curve should be assessed,
because any changes in its shape may reflect changes of the
particle size distribution during the MNP application and
may add to the information of the quantification results.
We classify the presented applications according to whether
single channel or multi channel devices are used for MRX
measurements.
Fig. 4 Magnetorelaxometry devices: (a) single channel device, the inset draft shows the centre part of the system with the 150 μl sample container in the
magnetizing coil about 12 mm below the SQUID sensor in the Dewar flask. (b) 18 channel MRX scanner with integrated superconducting shield. The
relaxation of samples and animals up to rabbit size are measured by circumferentially arranged 18 SQUID sensors (inset shows the sensor support chain)
located midway of the horizontal warm bore. (c) The PTB 304 channel vector magnetometer, the combination of this conventional biomagnetic
measurement system operated inside a magnetically shielded room with a (d) large Helmholtz coil system (d=84 cm, located in front of the shielded
room) allows MRX measurements on samples up to human size.
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samples or animals up to rabbit size. This system enables
MRX measurements in a typical laboratory environment, i.
e. outside a shielded room. The necessary shielding isSingle Channel MRX: Quantification of Magnetic
Nanoparticles in Tissue
Though of much less technical effort, single channel MRX
provides a useful tool for quantifying MNP in tissue. A crucial
issue in single channel MRX applications is the control of the
distance between sample and detectingsensor, because the field
of a magnetic dipole decays with the third power of the
distance. As a consequence small sample sizes are preferred,
with an extent that is much less than the distance to the sensor,
so that a point-like magnetic source can be assumed. For larger
sizedsamplesafavourablerelationbetweenextentanddistance
can be achieved by increasing the distance between sensor and
sample, but at the expense of reduced relaxation amplitude. To
give a practical example, for measurements of tissue samples in
a 8 ml container we usually increase this sample sensor distance
to about 40 mm.
Our single channel device magnetizes m = (0,0,mz)a n d
detects relaxation signals B = (0,0,Bz) solely in z-direction.
With the origin of the coordinate system at the sensor
position and the sample position at r’ =( 0 , 0 , z’) the magnetic
field of a magnetic moment according to Eq. 12 is given by
BzðzÞ¼
m0
2p
mz
jz   z0j
3 ð14Þ
A most efficient quantification procedure using single
channel MRX is to refer the sample relaxation amplitude
to the relaxation signal of a reference sample of known
MNP content measured under the same conditions. By this
we can bypass all peculiarities concerning the relaxation
magnetization induced during the MRX magnetizing phase
as described by Eq. 11.
Identical and Homogenous Sample Volumes. Typical appli-
cations are the quantification of the MNP content in blood
samples, in small defined tissue samples supplied by a
biopsy punch, or of MNP uptake by living cells (20). Here
the samples are of identical shape and with a uniform
magnetic nanoparticle distribution, so the nanoparticle
amount of the sample XMNP,sample is determined by the
ratio of the relaxation curve amplitudes
XMNP;sample ¼
ΔBz;sample
ΔBz;reference
XMNP;reference ð15Þ
With XMNP we denote either the total number NMNP of
MNP or the total iron mass m(Fe) in magnetic material
depending on our knowledge of the reference sample. The
iron amount of MNP reference samples is conveniently
determined by photometry.
An important constraint noteworthy for any reliable MRX
quantification is the congruence between sample and refer-
ence relaxation curve shape which assures that the MNP in
sample and reference exhibit the same distribution of
relaxation times. As an example Fig. 5a shows the relaxation
curves of a small tissue sample together with the relaxation
curves of two associated reference samples one with the
MNP immobilized by freeze drying and the other in the
original fluid state. The relaxation curve of the immobilized
reference nearly perfectly matches the curve shape of the
sample, thus being selected for the quantification.
Quantification of Small Irregularly Shaped Samples. In many
practicalcasestissuesamplesshowupinirregularshape.Thus,
by simply applying the procedure described in "Identical and
Homogenous Sample Volumes" quantification errors would
emerge because the distance between MNP accumulation
centre of the sample and SQUID sensor may differ from that
of the homogeneous reference sample as illustrated in Fig. 5c.
Examples are the quantification of uptake and clearance of
MNP by a small tumor or inadvertently by different organs
of small animals like mice, rats or rabbits.
In these cases the location of the magnetic source
(assumed to be point like) inside the sample volume a priori
is unknown, but can be determined by measuring the
sample twice reversing the sample about the known
distance d0 to the sensor, once in its normal posture and
once again placing the sample upside down into the
magnetizing coils as depicted in Fig. 5b.
Let z0 mark the distance between the center of the sample
container to the sensor and thus the rotation axis for the
sample reversion. Furthermore, d denotes the unknown
displacement of the dipole location, depicted as a red circle
in Fig. 5c, from position z0. So the dipole position is z’ = z0 + d
for the normal and z’ = z0-d for the reversed sample position.
Then, d =| z - z ’| can be extracted from Eq. 14 introducing the
ratio of the field amplitudes c = Bz,norm/Bz,rev
d ¼ z0
1   c1=3
1 þ c1=3 ð16Þ
Conveniently, the absolute distance z0 between rotation
axis and sensor is extracted from Eq. 16 by measuring the
magnetic field of a small calibrated cylindrical coil with
known magnetic moment supplied by a square-wave
alternating current, which is positioned at the rotation point.
In our example a displacement of d=9 mm was
calculated using a rotation point distance z0 of 37 mm as
determined by the calibration coil measurement. The
quantification is then performed by means of Eq. 15
with the measured relaxation amplitudes of sample and
reference first normalized to the distance z0 by
Bz;corr ¼ Bz;normðz0 þ dÞ
3=z3
0 ¼ Bz;revðz0   dÞ
3=z0
3.
As an example of this scenario, the quantification of MNP
in cell samples is described. In a cell culture experiment
complexes of MNP with lentiviruses, carrying the test gene
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duced to HUVECs (human umbilical vein endothelial cells) in
a magnetic field gradient. For quantification of the MNP
content within the cells after transduction, the HUVECs were
harvested, fixated, counted and transferred in vials for the
MRXmeasurement. Thecellsstackedat thebottomofthevial
by gravity forces, so that the spatial distribution of the sample
MNP distinguish from that of the reference sample, where the
MNP were equally distributed. Thus, the cell samples were
measured in up- and downward position and the center of
gravity of MNP was estimated by (16). We found a deviation
from the geometric center of the sample, 5 mm in height, of
(2.2±0.3)mmdownwards.Accordingly,inthegivensetup,the
quantification result was corrected by +35% compared to the
result which would be obtained by (15) being valid for a
homogeneous distribution of MNP in the measurement
sample. The amount of MNP, quantified down to 1 pg/cell,
correlated well with the gene expression, estimated by
measurement of the green fluorescence light (20).
Reconstructing the MNP Distribution in a Sample of Larger
Extension. The MRX approach based on "Quantification
of Small Irregularly Shaped Samples" can be utilized for
the spatially resolved quantitative reconstruction of a MNP
distribution throughout an extended tissue sample. This
was applied for ex-vivo quantification of MNP depositions in
pig lungs after magnetic aerosol targeting (21). As shown in
Fig. 6a the extracted lung lobe was first dissected into about
25 smaller pieces of about 2 cm
3 volume. Each of these was
quantified by MRX as described in "Quantification of Small
Irregularly Shaped Samples" to obtain the absolute MNP
content and then normalized to the corresponding tissue mass
(leading to values for iron concentration in the tissue: μgF e / g
tissue).Finally,combiningthesinglequantificationresultswith
the individual locations within the whole sample (see
photography Fig. 6b), the MNP concentration distribution
was reconstructed over the whole lung lobe with a centimetre
spatial resolution. For the example shown the MNP were
found nearly equally distributed over the whole lung lobe
with a three-fold higher MNP uptake in the area of the main
supplying bronchial tube. Additionally, the total absolute
nanoparticle deposition within the whole lung and differ-
ences between individual lung lobes were determined.
For the type of MNP used and the tissue pieces dissected
to fit into the 8 ml container, absolute iron amounts down
to approximately m(Fe)=200 ng could safely be detected.
By refining the sample dissection and using 150 ml sample
containers at the closest possible sample sensor distance
even a millimeter spatial resolution becomes feasible, with
the detection limit lowered to some 10 ng iron absolute.
Note that this can only be regarded a rough estimation
since the particular detection limit is to a large extent
dependent on type and size parameters of the individual
MNP used in an application.
Multi Channel MRX: Localization and Quantification
of Magnetic Nanoparticle Accumulations in Tissue
The application of the dissection procedure described in
"Reconstructing the MNP Distribution in a Sample of
Larger Extension" often becomes impractical for larger
sized samples or even impossible for in-vivo studies. In this
situation, often spatial information in terms of the magnetic
field distribution is of interest, because these data may help
to reconstruct the distribution of the nanoparticle density
within the tissue. This information can be obtained by
scanning a single channel SQUID system across the object,
Fig. 5 Quantifying the MNP amount of a small tissue sample by single channel MRX. (a) Relaxation curves of the sample piece together with immobilized
and fluid MNP reference signals. An arbitrary constant offset Bofs has been added to the relaxation curves solely for graphical representation. The blue
dotted (fluid) and the green dashed (immobilized) curves are the reference signals normalized to match the sample curve. The normalization factor directly
is proportional to the iron amount in the sample. (b) Determining the centre of a MNP accumulation in an irregularly shaped tissue sample by double
MRX measurement reversing the sample. (c) Individual relaxation curves of an irregularly shaped pig lung sample (inset picture) containing MNP . Together
with the relaxation curves of the sample measured in normal (dotted red curve) and upside down (dashed green) orientation the distance corrected
relaxation curve (straight black) is displayed.
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system. In a multi-channel system a number of magnetic
field sensors are located at different sites in a large Dewar
cryostat, which is positioned close to the sample. Depending
on the distance and orientation of the sensor with respect to
the object, the relaxation amplitude is different for each
sensor, while the detected time dependent relaxation curve
has the same shape (Fig. 7a). For a fixed sample, a multi-
channel system registers a steady magnetic field pattern
which decays monotonously in time (Fig. 7b).
A Single Point-Like MNP Accumulation. A single point-like
MNP accumulation is the simplest case of a nanoparticle
distribution, which is relatively easy to reconstruct from
multichannel MRX data. Even if the real situation is more
complicated, a point-like accumulation may be a useful
model that may help to obtain a first overview. Mathemat-
ically, the determination of location and amount of a point-
like magnetic nanoparticle accumulation from a measured
relaxation field pattern at a given time point t means the
inversion of Eq. 13.
This can be performed analytically if the direction of
the magnetic field during the magnetizing phase
coincides with the x-, y-,o rz-direction, so that the
localization of a point-like MNP accumulation can directly
be read off from a magnetic field pattern (22). With the
magnetizing field along the z-direction (x-direction) the
lateral x,y position is located at the maximum B+ of the
magnetic field pattern. The depth or z location is determined
by the radius R of the zero line circle surrounding the field
pattern, z =2
−1/2R, and the magnetic moment follows as
mz=(2π/μ0)z
3B+ (mx=(5
5/2π/(12μ0))d
3B+). With the mag-
netizing field applied along the x-direction the lateral x,y-
position is located half way between the two extreme values
Fig. 6 Single channel MRX on
dissected samples for quantitative
reconstruction of a MNP distribu-
tion after magnetic aerosol targeting
in a pig lung lobe (part. caudalis
dorsalis, numbers indicate μgi r o n / g
tissue. (a) MRX quantification
results of each tissue piece
normalized to tissue mass.
(b) Reconstruction of the nano-
particle distribution superimposed
onto a picture of the (intact)
lung lobe.
Fig. 7 Multi channel MRX of a
point-like MNP reference sample.
Left) Relaxation curves (57 Bz-
sensors) and corresponding mag-
netic field patterns at t=5 s, 45 s,
80 s. Right) Decay of magnetic
moments (mx,my,mz) of the MNP
determined by Levenberg-
Marquardt fitting and analytically
for mz from the magnetic field
pattern.
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distance between B+ and B−, while the magnetic moment
follows as mx =2 5 / 1 25
1/2π/μ0d
3 B+.
From four magnetic field patterns at t=5 s, 25 s, 45 s, and
80 s we determined a MNP accumulation localized at
x=22 mm, y=44 mm, and z=−68 mm) with the magnetic
moment decaying with time as displayed in Fig. 7b.W h e n
magnetizing along z-direction the MNP accumulation
centred below the 304ch device should be closer than 7 cm
to the sensor area (of radius 11 cm) since otherwise the zero
line of the field pattern would lie outside.
For an arbitrary magnetizing direction we use a non-
linear Levenberg-Marquardt algorithm for fitting the three
location parameters (x’,y’,z’) together with three magnetic
moment (mx(t),my(t),mz(t)) parameters of the MNP accumu-
lation describing best the corresponding magnetic field
pattern of each relaxation time point according to Eq. 13.
In this case, the location parameters x’,y’,z’ can be kept
fixed in the fitting procedure, because the object does not
move with respect to the sensor system. These results are
displayed for the moments in Fig. 7.
Similar to the single channel situation of "Identical and
Homogenous Sample Volumes", the absolute MNP
amount then follows by normalizing the magnetic moment
to the moment of a reference sample of known MNP
content measured and analyzed under same conditions.
Though strongly depending on particular MNP type and
sample properties MNP accumulations down to some μg
iron can reliably be quantified and the localization
accuracy often lies below one millimetre.
In-Vivo Localization and Quantification of a Magnetic Point-
Like MNP Accumulation. For in-vivo MRX measurements on
animals (or even humans), additional signals from the
respiration and muscle motion are superimposed to the
relaxation signals even if the animal is kept fixed. An even
greater challenge is the recording of a free moving
conscious animal, where the location of magnetic moment
of the MNP accumulation cannot be assumed constant for
the fitting procedure.
As an example we present the in-vivo localization and
quantification of a point like MNP accumulation in a
carcinoma mouse model in a magnetic thermoablation
treatment investigation (23) In this study, MNP were
injected into the tumor and subjected to an alternating
magnetic field which is absorbed by the particles and
dissipated by delivering heat to the surrounding tissue. To
assure an adequate heat production that kills the tumor
cells, quantity and position of the MNP need to be
continuously controlled. To this end, the location and
amount of the MNP accumulation were repeatedly deter-
mined by 304ch MRX measurements of the conscious
mouse, which was housed in a small cylindrically box.
Figure 8a shows the relaxation signal of a conscious
mouse after MNP injection recorded by a central SQUID
of the 304ch system together with corresponding field
patterns (Fig. 8a top) at selected time points. The
movement of the mouse becomes nicely visible in the field
patterns, while the relaxation curves of the individual
sensors detecting the magnetic field seem to be strongly
distorted (Fig. 8a). However, fitting the field patterns at
each time instant with the magnetic point dipole model
Eq. 13 allows the identification of the spatial movement of
the mouse (Fig. 8b) and the quantification of the magnetic
moment relaxation of the nanoparticles (Fig. 8c).
Reconstruction of Extended MNP Accumulations. For the
quantification and localization of magnetic nanoparticles
distributed over larger extended tissue areas the magnetic
point dipole is an inadequate model. Nonetheless, a
quantification and localization still can be accomplished
with appropriate adopted forward models. So far we have
two different approaches implemented for magnetorelax-
ometry. As a straightforward expansion the multiple point
dipoles model uses a number of point dipoles at predefined
locations within a sample for the description of the
measured magnetic relaxation field pattern (24). Addition-
ally, adjusting the direction of the magnetizing field, only
one parameter, the magnetic moment component pointing
into that direction, remains free for each of the dipoles.
Alternatively, at somewhat higher computational cost, the
measured magnetic relaxation field pattern can be analyzed
by means of a multipole expansion (25). The resulting set of
multipole coefficients in combination with an appropriate
choice of a magnetization distribution model enables
extracting important quantities like the total magnetic
moment, the location and even the extension of an
accumulation.
Investigating the Relaxation Curve Shape: Interactions
of Magnetic Nanoparticles with Their Biological
Environment
MNPs as Probes of the Local Hydrodynamic Environment
Magnetorelaxometry displays the superposition of signals
from all individual nanoparticles that are suspended in the
liquid of the sample. Even though this is an integral
approach to monitor the behaviour of magnetic nano-
particles, MNPs may serve as probes of the local hydrody-
namic environment. As it was pointed out in the
introduction, the Brownian relaxation time of a given
nanoparticle suspended in a fluid medium depends on its
hydrodynamic volume, which includes the nonmagnetic (e.g.
polymeric) shell surrounding the magnetic core as well as
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relaxation curve reflects the local hydrodynamic environment
of the MNP.
The organic molecules of the nanoparticle shell can be
covalently or ionically bound to reactive biomolecules. Any
conformational change or chemical reaction of these
biomolecules with analytes in the suspension will alter the
hydrodynamic shape of the MNP. By this mechanism, the
binding reaction of a biomolecule and an analyte can be
monitored in terms of a change of the relaxation behaviour,
so that MRX measurement data may even provide insight
into the microscopic behaviour of biochemical reactions.
A number of applications have been suggested that utilize
this mechanism, among them the so-called magnetic relaxation
immunoassay (MARIA) (26). In addition to the liquid phase
MRX immunoassay there are various assay layouts where the
analyte is not dissolved in the carrier medium (Fig. 9a)b u t
immobilized, e.g., by attaching it to a rigid surface (Fig. 9b)o r
to the surface of latex beads of much larger dimensions than
that of the MNP, say, with diameters of around a micrometer.
In such a setting, the Brownian relaxation is fully suppressed
by the binding reaction, so that only the Néel mechanism is
active, leading to a slower effective relaxation. In Fig. 9c,a
bead based assay is depicted, where the analyte is fixed to
l a r g eb e a d si nt h er a n g e0 . 1 . 1μm leading to a distinct change
in hydrodynamic size (27).
Yet another type of assay (Fig. 9d) is the agglutination assay,
which was recently suggested (28). In the agglutination assay,
both the MNP and the analyte exhibit multiple binding sites
so that at a certain concentration ratio the analytes give rise to
multiple cross-linking between the particles. This results in the
formation of large agglomerates, consisting of networks having
relatively large hydrodynamic diameters.
In general, a series of MRX measurements is necessary
to interpret the relaxation measurements in terms of
changes in the local hydrodynamic environment. The first
step is an MRX measurement that documents the initial
state of the MNP system under investigation. Then, the
physical parameters or the chemical composition of the
sample is altered eventually leading to a change in the
hydrodynamic behaviour of the MNPs, which is reflected
by changes of the MRX relaxation curve over subsequent
measurements. Control measurements with removed or
saturated binding sites both on MNPs and on the analyte
are in most cases appropriate to demonstrate the specificity
of the hydrodynamic changes.
In the following, three practical approaches that quantify
MRX curve shape changes are discussed: 1) the comparison
to reference curves for the relaxation of bound and
unbound nanoparticles, 2) the parameterization of the
relaxation curve by a typical relaxation time t1/e and 3)
modelling of the relaxation curve by assuming a special
distribution function for the hydrodynamic diameters.
Characterization of the Relaxation Curve by Reference Curves
In the case of the solid phase assay layout where the
rotational diffusion of the bound particles is fully sup-
pressed, the relaxation behavior of an individual particle
changes only upon the binding process, but remains
Fig. 8 304ch-MRX quantification of a magnetic nanoparticle accumulation in a conscious mouse: (a) the relaxation curve detection by the central SQUID
sensor starts some 10 s after switching off the magnetizing field and transporting the conscious mouse housed in a plastic tube beneath the MRX device.
Magnetic field pattern snapshots (top row) at time points t=16 s, 19 s, 24 s, 71 s, 86 s display the point-like dipolar character of a nanoparticle
accumulation moving relatively to the sensor positions. Fitting the field patterns for each point in time with the magnetic point dipole model Eq. 13 allows
(b) the identification of the spatial movement of the mouse and (c) the detection of magnetic moment relaxation of the nanoparticles. For comparison the
results for a fixed reference sample is added
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Thus, the task is to discriminate the signal contributions of
bound and unbound particles, where both fractions are
characterized by a well defined relaxation behavior. The
most effective way to obtain reference data for the
discrimination task is by measuring separately MRX curves
of nanoparticles in the bound and in the unbound state.
This is easily done by using samples of the nanoparticle
preparations in solution for the reference signal Bub(t)o f
unbound particles and freeze-dried samples for the reference
signal Bb(t) of bound and immobilized particles.
The measured relaxation curve B(t) is modelled as the
superposition b BðtÞ of the reference curves Bb(t) for bound
and Bub(t) for unbound MNP, complemented by an
arbitrary constant offset Boffs that cannot be avoided in
measurements using SQUIDs:
b BðtÞ¼a½bBbðtÞþð 1   bÞBubðtÞ  þ Boffs ð17Þ
The parameter a describes the iron content of the
measured sample in relation to that of the reference sample,
and β describes the fraction of bound MNP. In matrix
notation, Eq. 17 is written as:
b B ¼ Pz with P ¼ Bb Bub 1
  
and z
ab
að1   bÞ
Boffs
2
6 4
3
7 5 ð18Þ
The model is related to the vector of measured data B
by introducing a vector of model deviations u:
B ¼ b B þ u ¼ Pz þ u with u ¼
B1   b B1
. .
.
BK   b BK
2
6 6 6 4
3
7 7 7 5
ð19Þ
The unknown parameter vector z is found by minimizing
the variance of u which is satisfied for the ordinary least
square estimator zOLS:
zOLS ¼
ab
a 1   b ðÞ
Boffs
2
6 4
3
7 5  
k1
k2
Boffs
2
6 4
3
7 5 ¼ PþB ¼ PTP
    1PTB ð20Þ
Here, P
+ denotes the Moore-Penrose pseudoinverse of
P. The fraction of bound magnetic nanoparticles is then
easily calculated as β ¼ k1= k1 þ k2 ðÞ and the relative iron
content follows as a ¼ k1 þ k2.
Since an MRX measurement can be repeated in
intervals of a few seconds and washing steps are not
necessary, β can be updated with a temporal resolution of a
few seconds. Thus, the method may be used as a tool to
monitor the binding kinetics of a reaction that proceeds
within a corresponding time interval.
Fig. 9 Different kinds of MNP
based binding-assays for biomole-
cule detection by MRX: (a)
solid phase, (b) liquid phase, (c)
bead based, (d) agglutination assay
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In some assay types, e.g. in the agglutination assay (Fig.9d), the
distribution of hydrodynamic diameters of the colloidal
entities containing nanoparticles is permanently changing
throughout the binding process. Consequently, while the
distribution of magnetic core diameters will remain constant,
the distribution P(dh) of hydrodynamic diameters at a specific
time instant t is not known. In this case, it is impossible to use
reference curves for quantification of the binding process as it
w a sp r o p o s e di ns e c t i o n" C h a r a c t e r i z a t i o no ft h eR e l a x a t i o n
Curve by Reference Curves". Ap r a g m a t i cw a yt od o c u m e n t
a change in curve shape is given by computing t1/e, i.e. the
time when the amplitude of the relaxation signal has reached
1/e of its initial value. The total signal is the superposition of
all relaxation processes occurring with τeff = τeff(dp,dh)i nt h e
suspension. Especially for larger so-called “blocked” particles,
where τN >>tmeas, the effective relaxation time τeff is direct
proportional to the hydrodynamic volume Vh and all changes
in the hydrodynamic volume Vh are reflected in t1/e.
A significant rise in t1/e means increased hydrodynamic
diameters of the colloidal compartments and may indicate
aggregation processes. Thus, this method can provide an
efficient quality check of MNP suspensions.
Parameter Estimation for the Distribution of Hydrodynamic
Diameters
Under the assumption of a special distribution function for
the hydrodynamic diameters, the parameters of this
distribution can be estimated from the relaxation data. A
typical example is the assumption of a lognormal distribu-
tion of hydrodynamic diameters dh, as in Eq. 8. By fitting
this model to the measurement data via a nonlinear fitting
routine, the mean hydrodynamic diameter μh and the
distribution width σh can be estimated.
CONCLUSION
Magnetic nanoparticles have a wide range of applications in
medicine and biomedical research. Their physical properties
enable the measurement of a magnetic relaxation signal after
a rapid change of an external magnetic field. The relaxation
signaldependsoncoresizesandhydrodynamicvolumesofthe
MNPs. Because neither the surrounding biological environ-
ment nor any remanent magnetic material in the vicinity will
generate such relaxation signals, magnetorelaxometry is
highly specific for MNPs.
ThusthequantificationofMNPinlivingconsciousanimals
is feasible. The temporal decoupling from the large change in
excitation field allows one the use of ultrasensitive SQUID
sensors for readout of the magnetic relaxation signals. This
techniquetogetherwiththehighspecificity ofMRX measure-
ments make the quantitative determination of the MNP
content in large tissue samples down to a few picogram
possible. The analysis of the MNP relaxation curves enables
the observation of colloidal structure changes.
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